Cell Reports (Dec 2023)

Argonaute3-SF3B3 complex controls pre-mRNA splicing to restrain type 2 immunity

  • Riccardo Guidi,
  • Christopher Wedeles,
  • Daqi Xu,
  • Krzysztof Kolmus,
  • Sarah E. Headland,
  • Grace Teng,
  • Joseph Guillory,
  • Yi Jimmy Zeng,
  • Tommy K. Cheung,
  • Subhra Chaudhuri,
  • Zora Modrusan,
  • Yuxin Liang,
  • Stuart Horswell,
  • Benjamin Haley,
  • Sascha Rutz,
  • Christopher Rose,
  • Yvonne Franke,
  • Donald S. Kirkpatrick,
  • Jason A. Hackney,
  • Mark S. Wilson

Journal volume & issue
Vol. 42, no. 12
p. 113515

Abstract

Read online

Summary: Argonaute (AGO) proteins execute microRNA (miRNA)-mediated gene silencing. However, it is unclear whether all 4 mammalian AGO proteins (AGO1, AGO2, AGO3, and AGO4) are required for miRNA activity. We generate Ago1, Ago3, and Ago4-deficient mice (Ago134Δ) and find AGO1/3/4 to be redundant for miRNA biogenesis, homeostasis, or function, a role that is carried out by AGO2. Instead, AGO1/3/4 regulate the expansion of type 2 immunity via precursor mRNA splicing in CD4+ T helper (Th) lymphocytes. Gain- and loss-of-function experiments demonstrate that nuclear AGO3 interacts directly with SF3B3, a component of the U2 spliceosome complex, to aid global mRNA splicing, and in particular the isoforms of the gene Nisch, resulting in a dysregulated Nisch isoform ratio. This work uncouples AGO1, AGO3, and AGO4 from miRNA-mediated RNA interference, identifies an AGO3:SF3B3 complex in the nucleus, and reveals a mechanism by which AGO proteins regulate inflammatory diseases.

Keywords